SUPRIAX2™ is a next-generation bonded phospholipid omega-3 designed to take phospholipid nutrition beyond the limitations of conventional krill oil. Delivering 2X the EPA + DHA strength vs. krill oil, it gives brands a ready-to-commercialize hero ingredient for more advanced omega-3 formulations.
What sets SUPRIAX2™ apart is not simply how many phospholipids it contains, but how much omega-3 is actually bonded to them. Its advanced lipid architecture features EPA + DHA bonded to phospholipids rather than simply blending the two as separate components.
Why does bonding matter? Phospholipids are natural components of cell membranes and important lipid carriers in the body. Bonding EPA + DHA to phospholipids is designed to support the journey of omega-3 beyond absorption toward cellular incorporation.
With 2X the EPA + DHA strength vs. krill oil, SUPRIAX2™ enables more omega-3 in smaller, more efficient serving formats. It is also shellfish-free and designed for a neutral taste, helping brands move beyond key source and formulation limitations traditionally associated with krill.
The result is a differentiated hero ingredient for premium formulations supporting heart health, healthy aging, and overall wellness.
SUPRIAX2™ is built on the science behind Ruby-O®, Naturmega’s patented BPL-O3™ platform for bonded phospholipid omega-3. Ruby-O® enables the design of advanced lipid architectures across different omega-3 sources, phospholipid profiles, nutritional targets, and applications. SUPRIAX2™ translates that broader technology platform into a ready-to-commercialize solution designed specifically to go beyond krill.
Its scientific foundation combines NMR structural characterization and proprietary analytical methodologies benchmarking SUPRIAX2 vs krill oil, alongside pharmacokinetic and clinical research supporting the platform’s absorption and cellular incorporation story.
Don’t just count phospholipids. Ask how much omega-3 is bonded to them. Beyond Expecations
